Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus

Objective: To determine the prevalence of adverse health-related quality of life (HRQoL) outcomes in patients with SLE who achieved an adequate clinical response after a 52-week long standard therapy plus belimumab or placebo, and identify contributing factors. Methods: We included patients who met...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez, Alvaro, Qiu, Victor, Cederlund, Arvid, Borg, Alexander, Lindblom, Julius, Emamikia, Sharzad, Enman, Yvonne, Lampa, Jon, Parodis, Ioannis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085308/
https://www.ncbi.nlm.nih.gov/pubmed/33937290
http://dx.doi.org/10.3389/fmed.2021.651249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085308/
https://www.ncbi.nlm.nih.gov/pubmed/33937290
http://dx.doi.org/10.3389/fmed.2021.651249

Ejemplares similares